Visepegenatide
PB-119 is a PEGylated Exenatide. PB-119 decreases glycemic levels by improving beta-cell function and insulin resistance. PB-119 can be used for research of type 2 diabetes[1].
Product Specifications
CAS Number
2641081-54-9
Product Name Alternative
PB-119
UNSPSC
12352209
Target
Insulin Receptor
Type
Peptides
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/pb-119.html
Solubility
10 mM in DMSO
Smiles
[His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Cys-{PEG23K-Mal}-NH2]
Molecular Formula
(C2H4O) nC195H298N52O63S2
Molecular Weight
28000 (Approximately)
References & Citations
[1]Liu X, et al. PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naïve type 2 diabetes mellitus patients. Front Pharmacol. 2023 Sep 14;14:1088670.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-D439458-500MG 500 mg
N,N-Dicyclohexyl-2-benzothiazolsulfene Amide
Sign In for Pricing
View Details 
LC402868 20 µg
LGR7 (RXFP1) (NM_021634) Human Over-expression Lysate
Sign In for Pricing
View Details 
